Suzhou MedicalSystem Technology Co (603990) Fair Value & Analysis
Healthcare · CN · Market cap 6.6B CNY
Fair value as of: Jul 12, 2026
From 17 valuation models · updated today
Share price −3.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ¥13.81 – ¥22.96 · fair‑value band ¥1.63 – ¥2.14 · the ¥20.25 price screens above the ¥2.14 fair value. As of Jul 12, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Suzhou MedicalSystem Technology Co (603990) currently trades at ¥20.25, while our model-based Fair Value estimate is ¥2.14 — implying the stock looks roughly 89.4% overvalued today. We read business quality at 58/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Suzhou MedicalSystem Technology Co generated revenue of 300M CNY at a net margin of 6.5%. Revenue declined 2.6% year over year. It earns a return on equity of 2.5%. The balance sheet holds a net cash position of 18.0M CNY. Fundamentals as of Jul 12, 2026
Our scenario range runs from ¥1.63 (bear case) to ¥2.14 (bull case); at ¥20.25, the current price sits above that range. The share trades about 15% below its 52-week high and 47% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -33% fair-value upside — at -89%, 603990 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 12, 2026. TTM = trailing twelve months.
About the company
Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive auxiliary diagnosis clinical information system that mines and scientifically analyzes for ICU patients' treatment data with medical information, such as patients' treatment information, inspection information, nursing information, and doctor's advice data. In addition, it offers DoCare operative medical behavior management system that establishes the intelligent management system for the operation resources and personnel behavior; and DoCare emergency clinical information system for management of emergency clinical, including pre-hospital first aid, pre-examination and triage, emergency …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Suzhou MedicalSystem Technology Co reported revenue of ¥300M in FY2025 versus ¥354M in FY2021, a compound −4.1%/yr. Reported net income was ¥39.2M in FY2025, compounding −1.7%/yr from FY2021.
Is 603990 fairly valued? → Check now
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $153.16 | $183.66 | +20% |
| Pro Medicus Limited PME | A$165.64 | A$28.02 | -83% |
| BrightSpring Health Services, Inc BTSG | $57.40 | $23.87 | -58% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $84.61 | $79.57 | -6% |
| M3, Inc MTHRY | $5.20 | $5.32 | +2% |
| Hinge Health, Inc HNGE | $70.38 | $31.17 | -56% |
| Ping An Healthcare and Technology Company PANHF | $0.9000 | $0.6700 | -26% |
| 10x Genomics, Inc TXG | $31.04 | $20.68 | -33% |
| XtalPi Holdings 2228 | HK$7.48 | HK$1.03 | -86% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Suzhou MedicalSystem Technology Co (603990) undervalued?
What is the fair value of 603990?
What is the quality score of 603990?
What is the revenue of Suzhou MedicalSystem Technology Co (603990)?
What is the net profit margin of 603990?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Suzhou MedicalSystem Technology Co analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.